AnPac Bio-Medical Science Co., Ltd.
NASDAQ: ANPC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chris Chang Yu
- Employees
- 89
- Headquarters
- Lishui, China
- IPO year
- 2020
- Market cap
- $27.0M
- Website
- https://www.anpacbio.com
Loading ANPC…
Loading profile data…Frequently asked questions about ANPC
What does AnPac Bio-Medical Science Co., Ltd. (ANPC) do?
AnPac Bio-Medical Science Co., Ltd. is a biotechnology firm that specializes in developing and commercializing tests designed for the early detection and screening of various cancer types. These diagnostic tools leverage the company's unique Cancer Differentiation Analysis (CDA) technology and associated devices. AnPac Bio primarily provides the...
Where does ANPC trade?
AnPac Bio-Medical Science Co., Ltd. (ANPC) trades on the NASDAQ Capital Market.
What sector is ANPC in?
AnPac Bio-Medical Science Co., Ltd. (ANPC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of AnPac Bio-Medical Science Co., Ltd.?
Chris Chang Yu is the chief executive officer of AnPac Bio-Medical Science Co., Ltd. (ANPC).
Where is AnPac Bio-Medical Science Co., Ltd. headquartered?
AnPac Bio-Medical Science Co., Ltd. is headquartered in China.
Does ANPC pay a dividend?
AnPac Bio-Medical Science Co., Ltd. (ANPC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ANPC go public?
AnPac Bio-Medical Science Co., Ltd. (ANPC) completed its initial public offering in 2020.
Is ANPC an ADR?
Yes — ANPC is an American Depositary Receipt; its underlying shares trade on a non-US exchange. AnPac Bio-Medical Science Co., Ltd. reporting and dividends follow the underlying issuer.